首页 > 最新文献

Hepatobiliary surgery and nutrition最新文献

英文 中文
Pioneering the future of robotic liver surgery. 开创机器人肝脏手术的未来。
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-07-15 DOI: 10.21037/hbsn-24-312
Mohamed Elshaer
{"title":"Pioneering the future of robotic liver surgery.","authors":"Mohamed Elshaer","doi":"10.21037/hbsn-24-312","DOIUrl":"10.21037/hbsn-24-312","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"721-723"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336539/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trimming the fat myth: adipose tissue's role in liver regeneration. 修剪脂肪神话:脂肪组织在肝脏再生中的作用。
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-07-16 DOI: 10.21037/hbsn-24-181
Andrea Peloso, Nicolas Golse
{"title":"Trimming the fat myth: adipose tissue's role in liver regeneration.","authors":"Andrea Peloso, Nicolas Golse","doi":"10.21037/hbsn-24-181","DOIUrl":"10.21037/hbsn-24-181","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"727-731"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation. 用于肝切除术后大肠肝转移预后的机器学习模型:模型评估的几种策略。
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-06-25 DOI: 10.21037/hbsn-24-54
Guang-Yao Li, Lu-Lu Zhai
{"title":"A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation.","authors":"Guang-Yao Li, Lu-Lu Zhai","doi":"10.21037/hbsn-24-54","DOIUrl":"10.21037/hbsn-24-54","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"752-754"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advocating for the implementation of SonoVue microbubbles as pressure sensors: a call to action for clinical noninvasive pressure estimation. 倡导使用 SonoVue 微气泡作为压力传感器:呼吁采取行动进行临床无创压力估算。
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-07-18 DOI: 10.21037/hbsn-24-193
Ao Wen, Lingxiao Yang, Tao Lv, Huayu Yang, Fei Li, Yilei Mao, Gang Xu, Jia-Yin Yang
{"title":"Advocating for the implementation of SonoVue microbubbles as pressure sensors: a call to action for clinical noninvasive pressure estimation.","authors":"Ao Wen, Lingxiao Yang, Tao Lv, Huayu Yang, Fei Li, Yilei Mao, Gang Xu, Jia-Yin Yang","doi":"10.21037/hbsn-24-193","DOIUrl":"10.21037/hbsn-24-193","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"690-695"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and outcomes of robotic partial pancreatoduodenectomy. 机器人胰十二指肠部分切除术的可行性和结果。
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-07-16 DOI: 10.21037/hbsn-24-288
Antoine Rouault, Yasmina Richa, Mehdi El Amrani
{"title":"Feasibility and outcomes of robotic partial pancreatoduodenectomy.","authors":"Antoine Rouault, Yasmina Richa, Mehdi El Amrani","doi":"10.21037/hbsn-24-288","DOIUrl":"10.21037/hbsn-24-288","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"669-671"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome prediction after resection of colorectal cancer liver metastases: out with the old, in with the new? 结直肠癌肝转移灶切除术后的预后:新旧交替?
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-07-23 DOI: 10.21037/hbsn-24-187
Iakovos Amygdalos, Daniel Truhn, Florian W R Vondran
{"title":"Outcome prediction after resection of colorectal cancer liver metastases: out with the old, in with the new?","authors":"Iakovos Amygdalos, Daniel Truhn, Florian W R Vondran","doi":"10.21037/hbsn-24-187","DOIUrl":"10.21037/hbsn-24-187","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"732-735"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognosis of operated hepatocellular carcinoma developed on non-cirrhotic liver. 非肝硬化肝细胞癌手术后的预后。
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-07-01 DOI: 10.21037/hbsn-24-155
Morgan Vandermeulen, Maxime Dewulf, Olivier Detry
{"title":"Prognosis of operated hepatocellular carcinoma developed on non-cirrhotic liver.","authors":"Morgan Vandermeulen, Maxime Dewulf, Olivier Detry","doi":"10.21037/hbsn-24-155","DOIUrl":"10.21037/hbsn-24-155","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"736-738"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment. 特定的代谢损伤表明,在代谢功能障碍相关脂肪性肝病的治疗中,肝脏会失去持续的改善。
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-04-11 DOI: 10.21037/hbsn-23-393
Ling Luo, Junzhao Ye, Shuyu Zhuo, Bo Ma, Weiyi Mai, Xiaopei Cao, Liuqin Liang, Wei Wang, Shiting Feng, Zhi Dong, Bihui Zhong

Background: High liver fat content (LFC) induces increased risks of both hepatic and extrahepatic progression in metabolic dysfunction-associated steatotic liver disease (MASLD), while maintaining a significant decline in magnetic resonance imaging-based proton density fat fraction (MRI-PDFF) (≥30% decline relative to baseline) without worsening fibrosis results in improved histological severity and prognosis. However, the factors associated with the loss of sustained responses to treatment remain unclear, and we aim to identify them.

Methods: Consecutive treatment-naïve MASLD patients between January 2015 and February 2022, with follow-up until April 2023, were included in this prospective cohort study. LFC quantified by MRI-PDFF and liver stiffness measurements (LSM) determined by two-dimensional shear wave elastography (2D-SWE) were evaluated at weeks 0, 24 and 48. MRI-PDFF response was defined as a ≥30% relative decline in PDFF values, and LSM response was defined as a ≥1 stage decline from baseline.

Results: A total of 602 MASLD patients were enrolled. Of the 303 patients with a 24-week MRI-PDFF response and complete follow-up of 48 weeks, the rate of loss of MRI-PDFF response was 29.4%, and multivariable logistic regression analyses showed that 24-week insulin resistance (IR), still regular exercise and caloric restriction after 24 weeks, and the relative decline in LFC were risk factors for loss of MRI-PDFF response. Loss of LSM response at 48 weeks occurred in 15.9% of patients, and multivariable analysis confirmed 24-week serum total bile acid (TBA) levels and the relative decline in TBA from baseline as independent predictors. No significant association was found at 48 weeks between loss of MRI-PDFF response and loss of LSM response.

Conclusions: MASLD patients with IR and high TBA levels are at higher risks of subsequent diminished sustained improvements of steatosis and fibrosis, respectively.

背景:高肝脏脂肪含量(LFC)会增加代谢功能障碍相关性脂肪性肝病(MASLD)肝脏和肝外病变进展的风险,而保持基于磁共振成像的质子密度脂肪分数(MRI-PDFF)显著下降(相对于基线下降≥30%)且纤维化不恶化则会改善组织学严重程度和预后。然而,与治疗失去持续反应相关的因素仍不清楚,我们旨在找出这些因素:这项前瞻性队列研究纳入了 2015 年 1 月至 2022 年 2 月间连续接受治疗的 MASLD 患者,随访至 2023 年 4 月。在第0周、第24周和第48周对MRI-PDFF量化的LFC和二维剪切波弹性成像(2D-SWE)测定的肝脏僵硬度(LSM)进行评估。MRI-PDFF反应定义为PDFF值相对下降≥30%,LSM反应定义为与基线相比下降≥1个阶段:共有602名MASLD患者入组。多变量逻辑回归分析表明,24周胰岛素抵抗(IR)、24周后仍有规律的运动和热量限制以及LFC的相对下降是MRI-PDFF反应消失的风险因素。15.9%的患者在48周时丧失了LSM反应,多变量分析证实24周时血清总胆汁酸(TBA)水平和TBA较基线的相对下降是独立的预测因素。48周时,MRI-PDFF反应消失与LSM反应消失之间没有发现明显的关联:结论:具有IR和高TBA水平的MASLD患者随后分别出现脂肪变性和纤维化持续改善减弱的风险较高。
{"title":"Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment.","authors":"Ling Luo, Junzhao Ye, Shuyu Zhuo, Bo Ma, Weiyi Mai, Xiaopei Cao, Liuqin Liang, Wei Wang, Shiting Feng, Zhi Dong, Bihui Zhong","doi":"10.21037/hbsn-23-393","DOIUrl":"10.21037/hbsn-23-393","url":null,"abstract":"<p><strong>Background: </strong>High liver fat content (LFC) induces increased risks of both hepatic and extrahepatic progression in metabolic dysfunction-associated steatotic liver disease (MASLD), while maintaining a significant decline in magnetic resonance imaging-based proton density fat fraction (MRI-PDFF) (≥30% decline relative to baseline) without worsening fibrosis results in improved histological severity and prognosis. However, the factors associated with the loss of sustained responses to treatment remain unclear, and we aim to identify them.</p><p><strong>Methods: </strong>Consecutive treatment-naïve MASLD patients between January 2015 and February 2022, with follow-up until April 2023, were included in this prospective cohort study. LFC quantified by MRI-PDFF and liver stiffness measurements (LSM) determined by two-dimensional shear wave elastography (2D-SWE) were evaluated at weeks 0, 24 and 48. MRI-PDFF response was defined as a ≥30% relative decline in PDFF values, and LSM response was defined as a ≥1 stage decline from baseline.</p><p><strong>Results: </strong>A total of 602 MASLD patients were enrolled. Of the 303 patients with a 24-week MRI-PDFF response and complete follow-up of 48 weeks, the rate of loss of MRI-PDFF response was 29.4%, and multivariable logistic regression analyses showed that 24-week insulin resistance (IR), still regular exercise and caloric restriction after 24 weeks, and the relative decline in LFC were risk factors for loss of MRI-PDFF response. Loss of LSM response at 48 weeks occurred in 15.9% of patients, and multivariable analysis confirmed 24-week serum total bile acid (TBA) levels and the relative decline in TBA from baseline as independent predictors. No significant association was found at 48 weeks between loss of MRI-PDFF response and loss of LSM response.</p><p><strong>Conclusions: </strong>MASLD patients with IR and high TBA levels are at higher risks of subsequent diminished sustained improvements of steatosis and fibrosis, respectively.</p>","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"632-649"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can we talk about "futile surgery" for the upfront treatment of the perihilar cholangiocarcinoma? 对于肝周胆管癌的先期治疗,我们能谈论 "徒劳无益的手术 "吗?
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-07-23 DOI: 10.21037/hbsn-24-290
Maria Conticchio, David Fuks, Stylianos Tzedakis
{"title":"Can we talk about \"futile surgery\" for the upfront treatment of the perihilar cholangiocarcinoma?","authors":"Maria Conticchio, David Fuks, Stylianos Tzedakis","doi":"10.21037/hbsn-24-290","DOIUrl":"10.21037/hbsn-24-290","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"672-674"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142034408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines. 高危、重症和不宜手术患者急性胆囊炎治疗的进展与争议:意大利急诊外科和创伤学会指南。
IF 6.1 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-01 Epub Date: 2024-07-04 DOI: 10.21037/hbsn-24-324
Megan Vidal, Vladimir Neychev
{"title":"Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines.","authors":"Megan Vidal, Vladimir Neychev","doi":"10.21037/hbsn-24-324","DOIUrl":"10.21037/hbsn-24-324","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 4","pages":"724-726"},"PeriodicalIF":6.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hepatobiliary surgery and nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1